Glatiramer
Copaxone, Glatopa
NADAC/unit
$43.7485
No Shortage
Tier 1: 76.6%
PA Req: 336.8%
6 Manufacturers
12 ANDAs
Glatopa is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease,....
vs. brand Copaxone: Generic saves up to -337% per unit
Generic Manufacturers
CHEMI SPAHYBIO PHARMACEUTICAL CO LTDMYLAN PHARMACEUTICALS INCSANDOZ INCSCINOPHARM TAIWAN LTDSYNTHON PHARMACEUTICALS INCTEVA PHARMACEUTICALS USA
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.